⌕
Dexcom · DXCM · Nasdaq
Tenet 55 · Mixed
Compare
$82.04+0.53%At closeTenet 55 · Mixed
$82.04+0.43 (+0.53%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD
$81.98−0.06 (−0.07%)
After hours: Nov 17, 2026, 6:23 PM ET

Dexcom (DXCM) Stock

Dexcom (DXCM) closed at $82.04 on Nov 17, 2026; its Tenet Score is 55 of 100 against 340 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

5 figures withheld by our checks. Each blank figure names its reason.

Key stats

Close
$82.04
Nov 17, 2026
Market cap
$30.4B
share price × the latest quarter's diluted weighted-average share count (vendor)
P/E
31.6×
TTM through Sep 30, 2026 · as of close, Nov 16, 2026
52-week range
56.72 – 92.59
low → high · as of close, Nov 16, 2026
Tenet Score
55/100
Mixed · 340 Healthcare peers

Industry: Health Services

Dexcom Inc scores 55/100. Mixed. Strongest on quality and growth, value is the soft spot, trading at 32× earnings versus 340 Healthcare peers.

Tenet Score · vs sector

n=340
55/ 100
Mixed
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
39
Quality
73
Health
41
Growth
68

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueDQualityBHealthDGrowthCMomentumB
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/B
12.0×
Sep 30, 2026 balance sheet
P/S
6.0×
price to sales, TTM through Sep 30, 2026 · as of close, Nov 16, 2026
ROE
38%
TTM through Sep 30, 2026
Operating margin
19.6%
fiscal 2025, before interest and tax
Net margin
19.4%
TTM through Sep 30, 2026
Current ratio
1.74
Sep 30, 2026 balance sheet
Net debt / EBITDA
−0.4×
TTM through Sep 30, 2026
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Dexcom Inc

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as w…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=340) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 371 US ETFs · top wrappers by weightSee all ETFs holding DXCM →

Similar-sized companies in Health Services

The 10 companies in this industry closest in market cap, as of Nov 16, 2026.

Compare Dexcom with

What sector and industry is Dexcom in?

Dexcom is in the Healthcare sector and the Health Services industry.

What is Dexcom's Tenet Score?

Dexcom's Tenet Score is 55 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.